Method for the iontophoretic non-invasive determination of the in vivo concentration level of glucose

• US 5,730,714 A
• Filed: 09/26/1994
• Issued: 03/24/1998
• Est. Priority Date: 01/29/1988
• Status: Expired due to Term

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Hinz, Robert S., Rao, Girish, Guy, Richard, Glikfeld, Peretz, Cullander, Christopher
• Primary Examiner(s): Lacyk, John P.
• Application Number:
  US08/312,400
• Time in Patent Office: 1,275 Days
• Field of Search: 604/20, 128/639, 128/640, 128/749, 128/760, 128/762, 128/767, 607/115, 607/148, 607/152, 607/153
• US Class Current: 604/20
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61M 2037/0007 having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
• CPC Class Codes: A61N 1/303 Constructional details electrodes for external use A61N1/0428

Abstract

The present invention relates to an vitro device for the removal of ionized substances from a membrane sample without mechanical penetration, which device comprises:

(a) a positive electrode;

(b) a negative electrode, and

(c) electrical insulation between subpart (a) and (b), wherein the positive electrode, and the negative electrode, and electrical insulation are positioned on the same side of the membrane sample.

The present invention also relates to a device for the removal of or delivery of ionized substances to a mammal through intact skin or mucosal membrane without mechanical penetration, which device comprises: (a) a positive electrode, (b) a negative electrode, and (c) an electrically insulating material between subpart (a) and (b), wherein the positive electrode, negative electrode and insulating material are physically positioned so that each present a common surface of the device for contact with the same surface of the skin or mucosal membrane of the mammal.

The present invention also relates to the use of iontophoresis to determine the level of a charged molecule in a living mammal, and with the use of a feedback mechanism, administer appropriate levels of therapeutic substances.

Claims

1. An iontophoretic method for the substantially continuously in vivo monitoring of blood glucose in a mammal, the method comprising the steps of:

(a) placing a device comprised of a first electrically conducting means, a second electrically conducting means, and at least one collection reservoir on the skin or mucous membrane of the mammal to be monitored, wherein said second electrically conducting means is physically and electrically separated from said first electrically conducting means,

(b) connecting said device to an electrical source to create an electrical circuit,

(c) continuously applying a constant current in said electrical circuit to cause said blood glucose to migrate into said collection reservoir, and

(d) collecting and monitoring the glucose in said collection reservoir, with the proviso that the contact of the device on the skin or mucous membrane and the collection occurs at physiologically acceptable pH conditions.

2. The method of claim 1 additionally comprising the step of correlating the collected glucose to a glucose blood concentration.

3. The method of claim 1 wherein step (d) is accomplished using at least one analyzing device selected from the group consisting of a glucose or glucose metabolite biosensor, a glucose or glucose metabolite selective electrode, and a glucose or glucose metabolite specific colorimetric reagent, wherein said analyzing device is located in said collection reservoir.

4. The method of claim 3 wherein said analyzing device is linked to a glucose delivery device and the method further includes step

(e) delivery of glucose to the mammal in need of glucose.

5. The method of claim 3 wherein said analyzing device is linked to an alarm system to alert an operator that the monitored mammal requires additional glucose.

6. A method of monitoring glucose transferred from a source within mammalian tissue, the method comprising the following steps:

placing a glucose collector against the mammalian tissue surface;

substantially continuously transferring glucose from the source into the glucose collector; and

monitoring the glucose within the glucose collector, with the proviso that contact of the glucose collector with the tissue surface and the collection occur under physiologically acceptable pH conditions.

7. The method of claim 6 wherein the glucose collector uses a reservoir.

8. The method of claim 6 wherein the mammalian tissue is human skin.

9. The method of claim 8 wherein the method is performed in vivo.

10. The method of claim 6 wherein the transferring step uses iontophoresis.

11. The method of claim 10 further comprising the step of first placing an electrode against the mammalian tissue surface.

12. The method of claim 10 wherein the mammalian tissue is human skin.

13. The method of claim 12 wherein the method is performed in vivo.

14. The method of claim 6 wherein the monitoring step comprises measuring the concentration of glucose within the glucose collector.

15. A method of monitoring glucose metabolite transferred from a source across mammalian tissue, the method comprising the following steps:

placing a glucose metabolite collector against a tissue surface;

substantially continuously transferring glucose metabolite from the source into the glucose metabolite collector; and

monitoring the glucose metabolite within the glucose metabolite collector, with the proviso that contact of the glucose metabolite collector with the tissue surface and the collection occur under physiologically acceptable pH conditions.

16. The method of claim 15 wherein the glucose metabolite collector comprises a reservoir.

17. The method of claim 15 wherein the mammalian tissue is human skin.

18. The method of claim 17 wherein the method is performed in vivo.

19. The method of claim 15 wherein the transferring step uses iontophoresis.

20. The method of claim 19 further comprising the step of first placing an electrode against the mammalian tissue surface.

21. The method of claim 19 wherein the mammalian tissue is human skin.

22. The method of claim 21 wherein the method is performed in vivo.

23. The method of claim 15 wherein the monitoring step includes measuring the concentration of glucose metabolite within the glucose metabolite collector.